Skip to main content
Garrison-Morton-Norman History of Medicine

Biological Medical Product (Biologic)

Exhibiting 7 entries found in the GMN corpus.

Sort by YearSort by Author
YearTitle & TagsAuthor(s)
2019 CEA randomized, controlled trial of Ebola virus disease therapeutics.
MULANGU, Sabue
DODD, Lori E.
DODD, Lori E.
DAVEY, Richard T. Jr.
DAVEY, Richard T. Jr. & et al.
2013 CEBiologics. A history of agents made from living organisms in the twentieth century. Edited by Alexander von Schwerin, Heiko Stoff and Bettina Wahrig.
SCHWERIN, Alexander von STOFF, Heiko WAHRIG, Bettina
1989 CEBotulinum toxin: a treatment for facial asymmetry caused by facial nerve paralysis.
CLARK, Richard P.
CLARK, Richard P.
1975 CEContinuous cultures of fused cells secreting antibody of predefined specificity.
KÖHLER, Georges Jean Franz (1946 – 1995) MILSTEIN, César (1927 – 2002)
2016 CEProtective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody.
MULANGU, Sabue CORTI, Davide MISASI, John & et al.
2021 CEREGN-COV-2, a neutralizing antibody cocktail, in outpatients with Covid-19.
WEINREICH, David. M. SIVAPALASINGAM, Sumathi
NORTON, Thomas
NORTON, Thomas & et al.
2020 CEREGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters.
BAUM, Alina AJITHDOSS, Dharani K. KYRATSOUS, Christos A. & et al.